Covered recipient · General Payments record
SHISHIR K MAITHEL
Allopathic & Osteopathic Physicians Surgery Surgical Oncology
General Payments · PY2019–2024
$13,048.93
- Reported across 20 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $6,585.17 | 6 |
| Food and Beverage | $306.31 | 3 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $2,953.50 | 4 |
| F. Hoffmann-La Roche AG | $2,786.67 | 1 |
| Genentech, Inc. | $845.00 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $133.48 | 1 |
| Medtronic, Inc. | $126.64 | 1 |
| JAZZ PHARMACEUTICALS INC. | $46.19 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,074.00 | 01/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104486830 | CMS |
| AstraZeneca Pharmaceuticals LP | $268.50 | 01/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1104688162 | CMS |
| AstraZeneca Pharmaceuticals LP | $1,074.00 | 01/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105392708 | CMS |
| AstraZeneca Pharmaceuticals LP | $537.00 | 10/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105521727 | CMS |
| Boston Scientific Corporation | $133.48 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092387134 | CMS |
| F. Hoffmann-La Roche AG | $2,786.67 | 07/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133112911 | CMS |
| Genentech, Inc. | $845.00 | 08/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1133112915 | CMS |
| JAZZ PHARMACEUTICALS INC. | $46.19 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150230703 | CMS |
| Medtronic, Inc. | $126.64 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119468405 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.